期刊文献+

2013年版日本生物制剂治疗银屑病指南 被引量:2

下载PDF
导出
摘要 2010年1月,肿瘤坏死因子(TNF)-α单克隆抗体—阿达木单抗(adalimumab)和英夫利昔单抗(infliximab)开始用于临床治疗银屑病。2011年1月,人类抗白细胞介素-12/23p40(IL-12/23p40)单克隆抗体—乌司奴单抗(ustekinumab)作为第三种生物制剂,被新批准用于治疗银屑病。虽然所有这些生物制剂有望达到治疗银屑病的极佳疗效,并有助于提高患者的生活质量(QOL),但在使用这些药物之前,必须采取谨慎的安全措施以预防药物不良反应,如严重感染。本英文版指南基于2001年版日本生物制剂治疗银屑病指导及安全手册修订而成,旨在为生物制剂使用提供最新的、具有循证基础的建议和安全措施,并陈述了这三种生物制剂使用的最佳方案、使用生物制剂的医疗设施要求,避免激活结核和HBV感染的安全措施细节,并且推荐了生物制剂的联合治疗方案。
出处 《中国医药指南》 2014年第31期394-398,F0003,共6页 Guide of China Medicine
  • 相关文献

参考文献17

  • 1Ohtsuki M,Terui T, Ozawa A,et al.Guideline and safety manual for use of biologic agents in psoriasis (the 2011 version)[J].Jpn J Dermatol,2011,121(10):1561-1572.
  • 2Ohtsuki M,Terui T,Ozawa A,et al.The guideline and safety manual for use of anti-TNFa agents in psoriasis[J].Jpn J Dermato 1,2010,120(1):163-171.
  • 3JDA website.http://www.dermatol.or.jp/.
  • 4Iwatsuki K,Terui T, Ozawa A,et al.The guidelines for diagnosis and treatment of generalized pustular psoriasis 2010 (Treatment guidelines incorporating TNFa inhibitors) [J].Jpn J Dermato12010,120(7):815-839.
  • 5Asahina A,Nakagawa H,Etoh T, et al.Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis:efficacy and safety results from a phase 2/3 randomized controlled study[J].J Dermatol,2010,37(4):299-310.
  • 6Torii H,Nakagawa H.Japanese Infliximab Study Investigators. Infliximab monotherapy in Japanese patients with moderate- to-severe plaque psoriasis and psoriatic arthritis.A randomized,double-blind,placebo-controlled multicenter trial[J]. J Dermatol Sci,2010,59(1):40-49.
  • 7Igarashi A,Kato T, Kato M,et al.Japanese Us-tekianmab Study Group.Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis:long-term results from a phase 2/3 clinical trial[J].J Dermatol,2012,39(3):242-252.
  • 8Finlay AY.Current severe psoriasis and the rule of tens[J].Br J Dermatol,2005,152(5):861-867.
  • 9Menter A,Gottlieb A,Feldman SR,et al.Guidelines of care for the management of psoriasis and psoriatic arthritis.Section 1.Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics[J].J Am Acad Dermatol,2008,58(5):826-850.
  • 10Menter A,Korman NJ,Elmets CA,et al.Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 6.Guidelines of care for the treatment of psoriasis and psoriatic arthritis:case-based presentations and evidence-based conclusions[J].J Am Acad Dermatol,2011,65(1):137-174.

同被引文献14

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部